DTIL Stock Ownership Breakdown

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own DTIL shares is 64, representing 43.45% of the company's common stock.

CAPTRUST FINANCIAL ADVISORS, in the last quarter, reduced its stake in DTIL by -7.22% restricting it's holding to 113.48 thousand shares of worth nearly $41.42K. ARROWMARK COLORADO HOLDINGS LLC also lessened -4.48% of the DTIL shares from its portfolio, reducing its holding to 94.88 thousand shares of worth $34.63K. CAPITAL WORLD INVESTORS also shunned DTIL shares holding by -23.76% last quarter which brought its holding to 5.12 million shares worth $1.87M.

As per its latest 13F filing, increased its stake in DTIL by 100% in the last quarter. The institutional holder raised its holding to 27.23 thousand shares having worth more than $9.94K. VANGUARD GROUP INC also added 1.31% more shares of DTIL to its portfolio, raising its holding to 4.75 million shares of worth $1.74M. CITADEL ADVISORS LLC also increased its DTIL shares holding by 10.59% which brought its holding to 3.47 million shares worth $1.27M.

The insider with the most stakes in DTIL is JANTZ DEREK , Chief Scientific Officer at the company. Additionally, DTIL stock is highly held by FMR LLC and President and CEO KANE MATTHEW R. among others.

Company executives, directors, and other insiders own 6.4% percent of Precision BioSciences, Inc.'s stock. Within the last six months, there have been 5 transaction(s) in which DTIL insiders have sold stock, totaling 59.65K shares. Insiders that have sold shares include SMITH J. JEFFERSON, SCIMECA DARIO, and AMOROSO MICHAEL.

There have been 5 transaction(s) during the past 6-months in which Precision BioSciences, Inc. insiders have bought stock, totalling 16054 shares

Around 357.38K Precision BioSciences, Inc. shares are held by insiders, which represents about 6.4% of DTIL stock.

DTIL Chief Scientific Officer, JANTZ DEREK holds the largest portfolio of the company's shares. DTIL shares owned by JANTZ total nearly 4.06 million.

is the largest institutional owner in DTIL which holds 27.23 thousand shares worth $9.94K or 0.02% of the total DTIL shares outstanding followed by VANGUARD GROUP INC with ownership of 4.75 million shares representing 4.13% of the DTIL ownership. CITADEL ADVISORS LLC is the third largest stakeholder with 3.47 million shares or 3.01% of the ownership worth more than $1.27M.

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the DTIL is concerned, it is a stock which is not optionable.

Number of DTIL shares short is 306.66K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

As of today, 7.67M shares of DTIL are outstanding.

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, DTIL has 6.19M shares in float.

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for DTIL is 1.83.